Lyme Disease Is Spreading – Why Don’t We Have Drugs to Stop It?

Researchers are thinking about why preventive options against Lyme disease and tick-borne illnesses are more abundant for animals than humans. While pets benefit from vaccines and chewable treatments, human options are limited due to safety concerns and public hesitancy.

Past experiences with the Lyme vaccine, like Lymerix, led to withdrawal despite initial FDA approval. However, recent developments show promise, with new vaccines and oral medications undergoing human trials. Companies like Tarsus Pharmaceuticals are even exploring repurposing veterinary drugs, like the acaricide lotilaner, for human use. As tick-borne illnesses surge, such innovations could revolutionize public health strategies. Read more in the New York Times here.